{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:10:55Z","timestamp":1749636655001,"version":"3.40.2"},"reference-count":39,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Peripheral artery disease (PAD) is an atherosclerotic disease that contributes to significant morbidity and mortality, including loss of limb, myocardial infarction (MI), stroke, and death. Treatment options are often underutilized. A major limiting factor in PAD care is the ability to efficiently identify and screen at-risk patients. A PAD patient screening and clinician decision support tool was created to improve access to high-quality, evidence-based care to drive improved clinical outcomes. The tool identifies known PAD risk factors and presenting symptoms, in combination with objective data obtained via the ankle-brachial index (ABI). The tool utilizes this data to drive PAD diagnosis, risk assessment, and treatment, and it is adaptable across multiple care settings, by varied health professions. The implementation of a PAD screening and treatment toolkit enhances anticoagulation and PAD stewardship, and it has been integrated into use across various care settings.<\/jats:p>","DOI":"10.1515\/jom-2024-0050","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:31:46Z","timestamp":1730302306000},"page":"163-171","source":"Crossref","is-referenced-by-count":1,"title":["Improving peripheral artery disease screening and treatment: a screening, diagnosis, and treatment tool for use across multiple care settings"],"prefix":"10.1515","volume":"125","author":[{"given":"Kelly M.","family":"Rudd","sequence":"first","affiliation":[{"name":"Department of Medical Education , 33264 Oklahoma State University Center for Health Sciences Center College of Osteopathic Medicine , Tulsa , OK , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristie K.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Oklahoma State University Center for Health Sciences Center College of Osteopathic Medicine , Tahlequah , OK , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cooper M.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Oklahoma State University Center for Health Sciences Center College of Osteopathic Medicine , Tahlequah , OK , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"2025032407141368218_j_jom-2024-0050_ref_001","unstructured":"CDC. Peripheral arterial disease (PAD) | cdc.gov. Centers for Disease Control and Prevention; 2021. https:\/\/www.cdc.gov\/heartdisease\/PAD.htm [Accessed 10 Nov 2022]."},{"key":"2025032407141368218_j_jom-2024-0050_ref_002","doi-asserted-by":"crossref","unstructured":"Peach, G, Griffin, M, Jones, KG, Thompson, MM, Hinchliffe, RJ. Diagnosis and management of peripheral arterial disease. BMJ 2012;345:e5208. https:\/\/doi.org\/10.1136\/bmj.e5208.","DOI":"10.1136\/bmj.e5208"},{"key":"2025032407141368218_j_jom-2024-0050_ref_003","doi-asserted-by":"crossref","unstructured":"Peripheral artery disease\u00a0\u2013 what is peripheral artery disease? | NHLBI, NIH; 2022. https:\/\/www.nhlbi.nih.gov\/health\/peripheral-artery-disease [Accessed 7 Nov 2023].","DOI":"10.1201\/b23245-16"},{"key":"2025032407141368218_j_jom-2024-0050_ref_004","doi-asserted-by":"crossref","unstructured":"Selvin, E, Erlinger, TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999\u20132000. Circulation 2004;110:738\u201343. https:\/\/doi.org\/10.1161\/01.CIR.0000137913.26087.F0.","DOI":"10.1161\/01.CIR.0000137913.26087.F0"},{"key":"2025032407141368218_j_jom-2024-0050_ref_005","unstructured":"Home. Dartmouth Atlas of Health Care. https:\/\/www.dartmouthatlas.org\/ [Accessed 12 Dec 2022]."},{"key":"2025032407141368218_j_jom-2024-0050_ref_006","doi-asserted-by":"crossref","unstructured":"Bryce, Y, Katzen, B, Patel, P, Moreira, CC, Fakorede, FA, Arya, S, et al.. Closing the gaps in racial disparities in critical limb ischemia outcome and amputation rates: proceedings from a society of interventional radiology foundation research consensus panel. J Vasc Interv Radiol 2022;33:593\u2013602. https:\/\/doi.org\/10.1016\/j.jvir.2022.02.010.","DOI":"10.1016\/j.jvir.2022.02.010"},{"key":"2025032407141368218_j_jom-2024-0050_ref_007","doi-asserted-by":"crossref","unstructured":"Jindeel, A, Narahara, KA. Nontraumatic amputation: incidence and cost analysis. Int J Low Extrem Wounds 2012;11:177\u20139. https:\/\/doi.org\/10.1177\/1534734612457031.","DOI":"10.1177\/1534734612457031"},{"key":"2025032407141368218_j_jom-2024-0050_ref_008","doi-asserted-by":"crossref","unstructured":"Barnes, JA, Eid, MA, Creager, MA, Goodney, PP. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol 2020;40:1808\u201317. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314595.","DOI":"10.1161\/ATVBAHA.120.314595"},{"key":"2025032407141368218_j_jom-2024-0050_ref_009","doi-asserted-by":"crossref","unstructured":"Matsushita, K, Sang, Y, Ning, H, Ballew, SH, Chow, EK, Grams, ME, et al.. Lifetime risk of lower-extremity peripheral artery disease defined by ankle-brachial index in the United States. J Am Heart Assoc 2019;8:e012177. https:\/\/doi.org\/10.1161\/JAHA.119.012177.","DOI":"10.1161\/JAHA.119.012177"},{"key":"2025032407141368218_j_jom-2024-0050_ref_010","doi-asserted-by":"crossref","unstructured":"Gerhard-Herman, MD, Gornik, HL, Barrett, C, Barshes, NR, Corriere, MA, Drachman, DE, et al.. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. J Am Coll Cardiol 2017;69:1465\u2013508. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.008.","DOI":"10.1016\/j.jacc.2016.11.008"},{"key":"2025032407141368218_j_jom-2024-0050_ref_011","doi-asserted-by":"crossref","unstructured":"Gornik, HL, Aronow, HD, Goodney, PP, Arya, S, Brewster, LP, Byrd, L, et al.. 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 2024;149:e1313\u2013410. https:\/\/doi.org\/10.1161\/CIR.0000000000001251.","DOI":"10.1161\/CIR.0000000000001251"},{"key":"2025032407141368218_j_jom-2024-0050_ref_012","doi-asserted-by":"crossref","unstructured":"Feringa, HHH, Bax, JJ, Hoeks, S. A prognostic risk index for long-term mortality in patients with peripheral arterial disease. Arch Intern Med 2007;167:2482\u20139. https:\/\/doi.org\/10.1001\/archinte.167.22.2482.","DOI":"10.1001\/archinte.167.22.2482"},{"key":"2025032407141368218_j_jom-2024-0050_ref_013","unstructured":"Heart disease and stroke statistics\u00a0\u2013 2021 update. Circulation. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000950 [Accessed 12 Dec 2023]."},{"key":"2025032407141368218_j_jom-2024-0050_ref_014","doi-asserted-by":"crossref","unstructured":"Aboyans, V, Ricco, JB, Bartelink, MLEL, Bj\u00f6rck, M, Brodmann, M, Cohnert, T, et al.. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European stroke organization (ESO)the task force for the diagnosis and treatment of peripheral arterial diseases of the European society of cardiology (ESC) and of the European society for vascular surgery (ESVS). Eur Heart J 2018;39:763\u2013816. https:\/\/doi.org\/10.1093\/eurheartj\/ehx095.","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"2025032407141368218_j_jom-2024-0050_ref_015","doi-asserted-by":"crossref","unstructured":"H\u00f8yer, C, Sandermann, J, Petersen, LJ. The toe-brachial index in the diagnosis of peripheral arterial disease. J Vasc Surg 2013;58:231\u20138. https:\/\/doi.org\/10.1016\/j.jvs.2013.03.044.","DOI":"10.1016\/j.jvs.2013.03.044"},{"key":"2025032407141368218_j_jom-2024-0050_ref_016","doi-asserted-by":"crossref","unstructured":"Belch, JJF, Brodmann, M, Baumgartner, I, Binder, CJ, Casula, M, Heiss, C, et al.. Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: European atherosclerosis society\/European society of vascular medicine joint statement. Atherosclerosis 2021;338:55\u201363. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.09.022.","DOI":"10.1016\/j.atherosclerosis.2021.09.022"},{"key":"2025032407141368218_j_jom-2024-0050_ref_017","doi-asserted-by":"crossref","unstructured":"Thukkani, AK, Kinlay, S. Endovascular intervention for peripheral artery disease. Circ Res 2015;116:1599\u2013613. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303503.","DOI":"10.1161\/CIRCRESAHA.116.303503"},{"key":"2025032407141368218_j_jom-2024-0050_ref_018","doi-asserted-by":"crossref","unstructured":"Itoga, NK, Tawfik, DS, Lee, CK, Maruyama, S, Leeper, NJ, Chang, TI. Association of blood pressure measurements with peripheral arterial disease events: a reanalysis of the ALLHAT data. Circulation 2018;138:1805\u201314. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.033348.","DOI":"10.1161\/CIRCULATIONAHA.118.033348"},{"key":"2025032407141368218_j_jom-2024-0050_ref_019","doi-asserted-by":"crossref","unstructured":"Abramson, BL, Al-Omran, M, Anand, SS, Albalawi, Z, Coutinho, T, de Mestral, C, et al.. Canadian cardiovascular society 2022 guidelines for peripheral arterial disease. Can J Cardiol 2022;38:560\u201387. https:\/\/doi.org\/10.1016\/j.cjca.2022.02.029.","DOI":"10.1016\/j.cjca.2022.02.029"},{"key":"2025032407141368218_j_jom-2024-0050_ref_020","doi-asserted-by":"crossref","unstructured":"Sabouret, P, Cacoub, P, Dallongeville, J, Krempf, M, Mas, J, Pinel, J, et al.. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year. Arch Cardiovasc Dis 2008;101:81\u20138. https:\/\/doi.org\/10.1016\/s1875-2136(08)70263-8.","DOI":"10.1016\/S1875-2136(08)70263-8"},{"key":"2025032407141368218_j_jom-2024-0050_ref_021","doi-asserted-by":"crossref","unstructured":"Bhatt, DL, Peterson, ED, Harrington, RA, Ou, FS, Cannon, CP, Gibson, CM, et al.. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J 2009;30:1195\u2013202. https:\/\/doi.org\/10.1093\/eurheartj\/ehp099.","DOI":"10.1093\/eurheartj\/ehp099"},{"key":"2025032407141368218_j_jom-2024-0050_ref_022","doi-asserted-by":"crossref","unstructured":"Gutierrez, JA, Scirica, BM, Bonaca, MP, Steg, PG, Mosenzon, O, Hirshberg, B, et al.. Prevalence and outcomes of polyvascular (coronary, peripheral, or cerebrovascular) disease in patients with diabetes mellitus (from the SAVOR-TIMI 53 trial). Am J Cardiol 2019;123:145\u201352. https:\/\/doi.org\/10.1016\/j.amjcard.2018.09.014.","DOI":"10.1016\/j.amjcard.2018.09.014"},{"key":"2025032407141368218_j_jom-2024-0050_ref_023","doi-asserted-by":"crossref","unstructured":"Hirsh, J, Bhatt, DL. Comparative benefits of Clopidogrel and Aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. Arch Intern Med 2004;164:2106\u201310. https:\/\/doi.org\/10.1001\/archinte.164.19.2106.","DOI":"10.1001\/archinte.164.19.2106"},{"key":"2025032407141368218_j_jom-2024-0050_ref_024","doi-asserted-by":"crossref","unstructured":"Shu, J, Santulli, G. Update on peripheral artery disease: epidemiology and evidence-based facts. Atherosclerosis 2018;275:379\u201381. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.033.","DOI":"10.1016\/j.atherosclerosis.2018.05.033"},{"key":"2025032407141368218_j_jom-2024-0050_ref_025","unstructured":"Home. Dartmouth Atlas of Health Care. https:\/\/www.dartmouthatlas.org\/ [Accessed 12 Dec 2023]."},{"key":"2025032407141368218_j_jom-2024-0050_ref_026","doi-asserted-by":"crossref","unstructured":"Rizzo, JA, Chen, J, Laurich, C, Santos, A, Martinsen, BJ, Ryan, MP, et al.. Racial disparities in PAD-related amputation rates among native Americans and non-Hispanic Whites: an HCUP analysis. J Health Care Poor Underserved 2018;29:782\u2013800. https:\/\/doi.org\/10.1353\/hpu.2018.0058.","DOI":"10.1353\/hpu.2018.0058"},{"key":"2025032407141368218_j_jom-2024-0050_ref_027","doi-asserted-by":"crossref","unstructured":"Armstrong, EJ, Wu, J, Singh, GD, Dawson, DL, Pevec, WC, Amsterdam, EA, et al.. Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease. J Vasc Surg 2014;60:1565\u201371. https:\/\/doi.org\/10.1016\/j.jvs.2014.08.064.","DOI":"10.1016\/j.jvs.2014.08.064"},{"key":"2025032407141368218_j_jom-2024-0050_ref_028","doi-asserted-by":"crossref","unstructured":"Ding, N, Sang, Y, Chen, J, Ballew, SH, Kalbaugh, CA, Salameh, MJ, et al.. Cigarette smoking, smoking cessation, and long-term risk of 3 major atherosclerotic diseases. J Am Coll Cardiol 2019;74:498\u2013507. https:\/\/doi.org\/10.1016\/j.jacc.2019.05.049.","DOI":"10.1016\/j.jacc.2019.05.049"},{"key":"2025032407141368218_j_jom-2024-0050_ref_029","doi-asserted-by":"crossref","unstructured":"Jonason, T, Bergstr\u00f6m, R. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 1987;221:253\u201360. https:\/\/doi.org\/10.1111\/j.0954-6820.1987.tb00891.x.","DOI":"10.1111\/j.0954-6820.1987.tb00891.x"},{"key":"2025032407141368218_j_jom-2024-0050_ref_030","doi-asserted-by":"crossref","unstructured":"Bryce, Y, Katzen, B, Patel, P, Moreira, CC, Fakorede, FA, Arya, S, et al.. Closing the gaps in racial disparities in critical limb ischemia outcome and amputation rates: proceedings from a society of interventional radiology foundation research consensus panel. J Vasc Interv Radiol 2022;33:593\u2013602. https:\/\/doi.org\/10.1016\/j.jvir.2022.02.010.","DOI":"10.1016\/j.jvir.2022.02.010"},{"key":"2025032407141368218_j_jom-2024-0050_ref_031","doi-asserted-by":"crossref","unstructured":"Al-Qaisi, M, Nott, DM, King, DH, Kaddoura, S. Ankle brachial pressure index (ABPI): an update for practitioners. Vasc Health Risk Manag 2009;5:833\u201341. https:\/\/doi.org\/10.2147\/vhrm.s6759.","DOI":"10.2147\/VHRM.S6759"},{"key":"2025032407141368218_j_jom-2024-0050_ref_032","doi-asserted-by":"crossref","unstructured":"Aboyans, V, Criqui, MH, Abraham, P, Allison, MA, Creager, MA, Diehm, C, et al.. Measurement and interpretation of the ankle-brachial index. Circulation 2012;126:2890\u2013909. https:\/\/doi.org\/10.1161\/CIR.0b013e318276fbcb.","DOI":"10.1161\/CIR.0b013e318276fbcb"},{"key":"2025032407141368218_j_jom-2024-0050_ref_033","doi-asserted-by":"crossref","unstructured":"Barrera-Guarderas, F, Carrasco-Tenezaca, F, De la Torre-Cisneros, K. Peripheral artery disease in type 2 diabetes mellitus: survival analysis of an Ecuadorian population in primary care. J Prim Care Community Health 2020;11. https:\/\/doi.org\/10.1177\/2150132720957449.","DOI":"10.1177\/2150132720957449"},{"key":"2025032407141368218_j_jom-2024-0050_ref_034","doi-asserted-by":"crossref","unstructured":"Aboyans, V, Bauersachs, R, Mazzolai, L, Brodmann, M, Palomares, JFR, Debus, S, et al.. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. Eur Heart J 2021;42:4013\u201324. https:\/\/doi.org\/10.1093\/eurheartj\/ehab390.","DOI":"10.1093\/eurheartj\/ehab390"},{"key":"2025032407141368218_j_jom-2024-0050_ref_035","doi-asserted-by":"crossref","unstructured":"Conte, MS, Bradbury, AW, Kolh, P, White, JV, Dick, F, Fitridge, R, et al.. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg 2019;58:S1\u2013109.e33. https:\/\/doi.org\/10.1016\/j.ejvs.2019.05.006.","DOI":"10.1016\/j.ejvs.2019.05.006"},{"key":"2025032407141368218_j_jom-2024-0050_ref_036","unstructured":"Anand, SS, Bosch, J, Eikelboom, JW, Connolly, SJ, Diaz, R, Widimsky, P, et al., COMPASS Investigators. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 2018;391:219\u201329. https:\/\/doi.org\/10.1001\/jamacardio.2020.4390t."},{"key":"2025032407141368218_j_jom-2024-0050_ref_037","doi-asserted-by":"crossref","unstructured":"Bauersachs, RM, Szarek, M, Brodmann, M, Gudz, I, Debus, ES, Nehler, MR, et al., VOYAGER PAD Committees and Investigators. Total ischemic event reduction with Rivaroxaban after peripheral arterial revascularization in the VOYAGER PAD trial. J Am Coll Cardiol 2021;78:317\u201326. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050465.","DOI":"10.1016\/j.jacc.2021.05.003"},{"key":"2025032407141368218_j_jom-2024-0050_ref_038","unstructured":"Social determinants of health\u00a0\u2013 healthy people 2030 | health.gov. https:\/\/health.gov\/healthypeople\/priority-areas\/social-determinants-health [Accessed 8 Jul 2024]."},{"key":"2025032407141368218_j_jom-2024-0050_ref_039","unstructured":"PAD resources. www.heart.org. https:\/\/www.heart.org\/en\/health-topics\/peripheral-artery-disease\/pad-resources [Accessed 27 Dec 2023]."}],"container-title":["Journal of Osteopathic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jom-2024-0050\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jom-2024-0050\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:14:55Z","timestamp":1742800495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jom-2024-0050\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,11,25]]},"published-print":{"date-parts":[[2025,3,24]]}},"alternative-id":["10.1515\/jom-2024-0050"],"URL":"https:\/\/doi.org\/10.1515\/jom-2024-0050","relation":{},"ISSN":["2702-3648"],"issn-type":[{"type":"electronic","value":"2702-3648"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}